Compare Teucrium Soybean Fund (SOYB) vs Zoetis Inc (ZTS) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Teucrium Soybean Fund vs Zoetis Inc — how do they compare? Teucrium Soybean Fund trades at $27.57 (market cap $43.52M), while Zoetis Inc trades at $74.77 (market cap $30.20B). The key difference: Zoetis Inc is far larger — about 693.9× Teucrium Soybean Fund's market cap, and Zoetis Inc pays a 2.9% dividend while Teucrium Soybean Fund pays none. Which is the better fit depends on your goals — on Pluang, investors hold Teucrium Soybean Fund for 23 Days and Zoetis Inc for 70 Days on average.
| SOYB | ZTS | |
|---|---|---|
Market Cap | $43.52M | $30.20B |
Volume | 32,585 | 6,175,327 |
Sector | Commodities - Metals/Agriculture | Health |
52-Week High | $28.14 | $147.53 |
52-Week Low | $21.55 | $69.09 |
Typical Hold Time | 23 Days | 70 Days |
Enterprise Value | — | $37.76B |
Dividend Yield | — | 2.9% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SOYB trades at $27.57, down slightly by 0.07% today, with a bullish technical signal driven by strong moving average alignment. Recent news highlights potential catalysts from U.S.-China trade talks and agricultural commodity trends. Key support and resistance are tightly clustered around $27 and $28, indicating a consolidation phase.
The outlook is cautiously optimistic due to positive technical momentum and geopolitical developments, but fundamental data is unavailable, limiting valuation clarity. Risks include trade negotiation outcomes and broader commodity market volatility, requiring careful monitoring of upcoming earnings and guidance for a complete investment picture.
Zoetis (ZTS) trades at $73.08, up 2.14% today, with a bullish technical signal but mixed earnings history including a recent Q1 2026 miss. The stock shows strong profitability with a 27.69% net income margin and 64.91% ROE, while valuation metrics like a P/E of 11.92 appear reasonable. Recent news highlights competitive pressures in the U.S. pet care market, though international segments remain resilient.
The outlook is cautiously optimistic; ZTS faces near-term headwinds from weak U.S. demand and competition, but its industry-leading margins and dominant market position support long-term growth. Risks include pricing erosion and guidance cuts, yet the consensus price target of $87.33 suggests upside potential for patient investors.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
About Teucrium Soybean Fund
SOYB is a commodity ETF that provides exposure to the price of soybean futures. It utilizes a laddered strategy by investing in several benchmark futures contracts to reduce the impact of roll costs and contango in the agricultural market.
Read more on SOYB →About Zoetis Inc
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns slightly less than half of total revenue from production animals (cattle, pigs, poultry, and so on), and more than half from companion animal (dogs, horses, cats) products make up the other half. Its U.S. business is heavily skewed toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.
Read more on ZTS →
